A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2011
09/27/2011	CA2647206C N-carbamoylmethyl-4-(r)-phenyl-2-pyrrolidinone, method of its preparation and pharmaceutical use
09/27/2011	CA2615611C Indazole derivatives
09/27/2011	CA2608848C Fad4, fad5, fad5-2, and fad6, novel fatty acid desaturase family members and uses thereof
09/27/2011	CA2531620C Cancer combination therapy comprising azd2171 and zd1839
09/27/2011	CA2530005C Use of buprenorphine for the treatment of drug dependence withdrawal in a pregnant woman
09/27/2011	CA2511307C Viral polymerase inhibitors
09/27/2011	CA2510280C Process for the preparation of the r,r (or s,s) configured glycopyrronium stereoisomer
09/27/2011	CA2506476C Method of treatment of myocardial infarction
09/27/2011	CA2505742C Pharmaceutical compositions comprising a basic drug, a water soluble acid and a surfactant
09/27/2011	CA2503646C Heteroaryloxy-substituted phenylaminopyrimidines as rho-kinase inhibitors
09/27/2011	CA2501751C A combination therapy for hiv infections
09/27/2011	CA2495864C Aripiprazole complex formulation and method
09/27/2011	CA2495280C Topical pharmaceutical carrier
09/27/2011	CA2493815C Nucleoside compounds and their use for treating cancer and diseases associated with somatic mutations
09/27/2011	CA2490309C Anthelmintic oral homogeneous veterinary pastes
09/27/2011	CA2487542C Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides
09/27/2011	CA2475930C 3-alkanoylamino-propionic acid derivatives used as inhibitors of integrin avss6
09/27/2011	CA2473409C Phenoxy-piperidines for the treatment of diseases such as schizophrenia and depression
09/27/2011	CA2467723C Method for treating cervical cancer
09/27/2011	CA2463999C Drug delivery system for conscious sedation
09/27/2011	CA2463865C Dimeric compounds and their use as anti-viral agents
09/27/2011	CA2463835C Dimeric compounds and their use as anti-viral agents
09/27/2011	CA2462337C Dimeric compounds and their use as anti-viral agents
09/27/2011	CA2457410C Compounds effecting glucokinase
09/27/2011	CA2453486C The natural ligand for orphan g protein coupled receptor gpr86 and methods of use
09/27/2011	CA2440630C Metalloproteinase inhibitors
09/27/2011	CA2440042C Carboxamide derivatives as therapeutic agents
09/27/2011	CA2418109C Polymorphs of an epothilone analog
09/27/2011	CA2415847C Aminoalkylbenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same
09/27/2011	CA2412600C Potent immunostimulatory polysaccharides extracted from microalgae
09/27/2011	CA2403790C A cell division inhibitor and a production method thereof
09/27/2011	CA2400462C Aspirin-triggered lipid mediators
09/27/2011	CA2386514C Antifungal enediynes
09/27/2011	CA2370206C Pharmaceutical compositions for inhibition of cytokine production and secretion
09/27/2011	CA2258728C Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase
09/25/2011	CA2735107A1 Co-precipitated salts of fatty acids
09/24/2011	CA2734619A1 Therapeutic implant
09/22/2011	WO2011116399A1 Novel methods for targeting cancer stem cells
09/22/2011	WO2011116398A1 Novel compounds and compositions for targeting cancer stem cells
09/22/2011	WO2011116397A1 Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
09/22/2011	WO2011116392A2 Use of p2x purinergic receptor agonists to enhance insulin secretion in pancreatic beta cells
09/22/2011	WO2011116356A2 Positive allosteric modulators of group ii mglurs
09/22/2011	WO2011116355A2 Benzoisothiazolones as inhibitors of phosphomannose isomerase
09/22/2011	WO2011116348A1 Boron-containing small molecules as anti-protozoal agent
09/22/2011	WO2011116336A1 Nitroxyl (hno) releasing compounds and uses thereof in treating diseases
09/22/2011	WO2011116299A2 Myeloid derived suppressor cell inhibiting agents
09/22/2011	WO2011116292A1 Combination compositions of adenosine a1 agonists and non-selective beta-adrenergic receptor blockers for reducing intraocular pressure
09/22/2011	WO2011116290A1 Combination compositions of adenosine a1 agonists and carbonic anhydrase inhibitors for reducing intraocular pressure
09/22/2011	WO2011116287A1 Ccr5 modulators for treating hiv
09/22/2011	WO2011116286A2 Stable bortezomib formulations
09/22/2011	WO2011116282A2 Nicotinic acetylcholine receptor agonists
09/22/2011	WO2011116277A1 Perfluorocarbon eye cream formulations
09/22/2011	WO2011116176A1 3-substitued imidazo (4, 5-b) pyridines and analogs as sirtuin modulators
09/22/2011	WO2011116161A2 Arylsulfonamide ccr3 antagonists
09/22/2011	WO2011116123A1 Tafamidis for the treatment of ophthalmic diseases
09/22/2011	WO2011116115A1 Aliskiren composition comprising a medium chain fatty acid, their process of manufacturing
09/22/2011	WO2011116107A2 Cleavable modifications to reducible poly (amido ethylenimines)s to enhance nucleotide delivery
09/22/2011	WO2011116066A1 Derivatives of dimethylcurcumin
09/22/2011	WO2011116020A2 Ophthalmic formulations of cetirizine and methods of use
09/22/2011	WO2011115998A2 Modulators of hec1 activity and methods therefor
09/22/2011	WO2011115943A1 A substituted pyrimidine as a prostaglandin d2 receptor antagonist
09/22/2011	WO2011115940A1 Substituted pyrimidines as prostaglandin d2 receptor antagonists
09/22/2011	WO2011115938A1 Spiro-tetracyclic ring compounds as beta - secretase modulators
09/22/2011	WO2011115928A1 Amino -dihydrooxazine and amino - dihydrothiazine spiro compounds as beta - secretase modulators and their medical use
09/22/2011	WO2011115922A1 Treatment for pulmonary hypertension
09/22/2011	WO2011115892A1 Modulators of the retinoic acid receptor-related orphan receptors
09/22/2011	WO2011115862A1 Endosomolytic poly(amidoamine) disulfide polymers for the delivery of oligonucleotides
09/22/2011	WO2011115861A2 Antimicrobial compositions comprising trimethylene glycol oligomer and methods of using the compositions
09/22/2011	WO2011115813A1 Lactam acetamides as calcium channel blockers
09/22/2011	WO2011115810A2 Isoform-specific rnai based on codon redundancy/degeneracy
09/22/2011	WO2011115804A1 Sgc stimulators
09/22/2011	WO2011115778A2 Aerosolized dapsone as a therapy for inflammation of the airway and abnormal mucociliary transport
09/22/2011	WO2011115763A1 Inhibitors of the tumor necrosis factor receptor complex
09/22/2011	WO2011115733A1 Risperidone immunoassay
09/22/2011	WO2011115725A2 Indazole compounds and their uses
09/22/2011	WO2011115700A2 Emollient foams for treatment of seborrheic dermatitis
09/22/2011	WO2011115687A2 Alkylated sp-b peptoid compounds and related lung surfactant compositions
09/22/2011	WO2011115677A1 S-triazine compounds, pharmaceutical compositions and methods of using the same
09/22/2011	WO2011115639A1 Microbially-stable vitamin e solutions
09/22/2011	WO2011115599A2 Orally disintegrating tablet formulations of donepezil and process for preparing the same
09/22/2011	WO2011115585A1 Pharmaceutical combination of acetylsalicylic acid and antifungal compound for destroying or growth inhibition and reproduction of fungi
09/22/2011	WO2011115527A1 New biologically active compound n-[3-(4-nitrophenylamino)-indol-2-ylmethylene]aminoguanidine hydrochloride with anti-inflammatory activity
09/22/2011	WO2011115513A2 A cytosine analogue, a method of preparation of a cytosine analogue, a dna methyltransferase 1 inhibitor, a method for dna methylation inhibition, the use of the analogue in the treatment of diseases associated with deviations from normal dna methylation
09/22/2011	WO2011115491A1 Infant nutrition for improving fatty acid composition of brain membranes
09/22/2011	WO2011115490A1 Infant nutrition for improving fatty acid composition of brain membranes
09/22/2011	WO2011115479A1 Use of anticoagulants in the production of recombinant proteins in the milk of transgenic animals
09/22/2011	WO2011115476A1 Infant nutrition for improving fatty acid composition of brain membranes later in life
09/22/2011	WO2011115271A1 Tumor angiogenesis inhibitor
09/22/2011	WO2011115268A1 Tumor angiogenesis inhibitor
09/22/2011	WO2011115246A1 Ebna1 function inhibitor
09/22/2011	WO2011115184A1 Inhibitor of in vivo proteolysis
09/22/2011	WO2011115183A1 Novel monocyclic pyrimidine derivative
09/22/2011	WO2011115173A1 Monomaleate of benzothiazine compound
09/22/2011	WO2011115067A1 Method for improving dissolvability of anticoagulant
09/22/2011	WO2011115066A1 Crystal of diamine derivative and method of producing same
09/22/2011	WO2011115065A1 Cyclopropanecarboxylic acid derivative
09/22/2011	WO2011115064A1 Cycloalkyl-substituted imidazole derivative
09/22/2011	WO2011115062A1 Adjuvant having anti-tumor effect
09/22/2011	WO2011114346A1 Chitin and related compounds for use in treating bacterial and viral infections
09/22/2011	WO2011114275A1 Spirocyclic compounds and their use as therapeutic agents and diagnostic probes

1 ... 1551 1552 1553 1554 1555 1556 1557 1558 1559 1560 1561 1562 1563 1564 1565 1566 1567 1568 1569 1570 1571 ... 7860